Cargando…
Antifibrotic role of low-dose mitomycin-c-induced cellular senescence in trabeculectomy models
PURPOSE: We assessed whether mitomycin-C (MMC) has different antifibrotic mechanisms in trabeculectomy wound healing. METHODS: We identified 2 concentrations of MMC as “low-dose” by using WST-1 assay, Lactic dehydrogenase assay, and fluorescence-activated cell sorting flow cytometry. Senescence-asso...
Autores principales: | Lin, Le-Tien, Chen, Jiann-Torng, Lu, Da-Wen, Tai, Ming-Cheng, Liang, Chang-Min, Chen, Ching-Long, Pao, Shu-I, Hsu, Chih-Kang, Chen, Yi-Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310836/ https://www.ncbi.nlm.nih.gov/pubmed/32574191 http://dx.doi.org/10.1371/journal.pone.0234706 |
Ejemplares similares
-
Comparison of the Outcome of Repeat Trabeculectomy with Adjunctive Mitomycin C and Initial Trabeculectomy
por: Cankaya, Ali Bulent, et al.
Publicado: (2011) -
Surgical outcomes of repeat trabeculectomy augmented with high dose mitomycin C
por: Rajendrababu, Sharmila, et al.
Publicado: (2019) -
Repression of Smad4 by MicroRNA-1285 moderates TGF-β-induced epithelial–mesenchymal transition in proliferative vitreoretinopathy
por: Pao, Shu-I, et al.
Publicado: (2021) -
MicroRNA-4516 suppresses proliferative vitreoretinopathy development via negatively regulating OTX1
por: Pao, Shu-I, et al.
Publicado: (2022) -
No effects of mitomycin-C in primary trabeculectomies in Sweden
por: Ayala, Marcelo
Publicado: (2018)